There are several consistent reports that link risk of prostate cancer with high serum levels of IGF-I (Mantzoros et al, 1997; Chan et al, 1998; Wolk et al, 1998; Stattin et al, 2000; Chokkalingam et al, 2001). Here, IGF1 is linked to prostate carcinoma.